The company said its revenue rose to US$2.76 billion in the nine months ended Sept. 30 last year
Author of the article:
Reuters
Mehnaz Yasmin and Ananya Mariam Rajesh
Boxes of Bausch + Lomb Inc. Sensitive Eyes contact lens solution at a pharmacy in the Brooklyn borough of New York. Photo by Jonathan Fickies/Bloomberg News files Eye-care products maker Bausch + Lomb Corp on Thursday filed to go public in the United States and Canada through an initial public offering and disclosed a jump in sales for the first time.
Advertisement This advertisement has not loaded yet, but your article continues below.
The company said its revenue rose to US$2.76 billion in the nine months ended Sept. 30 last year from US$2.47 billion in the same period a year earlier, it said in a filing .
It seeks to sell up to US$100 million worth of shares, a placeholder amount used to calculate filing fees, and aims to use the amount to further expand its business.
The 169-year-old company that started as a small optical goods shop in New York in 1853 currently supplies branded and generic pharmaceuticals, contact lenses and lens care products to 150 million people in more than 90 countries.
More On This Topic Battle between commodity and tech sectors heats up — time to choose sides FP Explains: How target-date funds can help you hit the retirement bullseye FP Answers: Is it worth it leveraging my HELOC to invest in dividend-paying ETFs? This advertisement has not loaded yet, but your article continues below.
Article content It was first listed on the New York Stock Exchange in 1958, but was taken private in 2007 when it was acquired by Warburg Pincus.
In 2013, Canadian drugmaker and parent company Bausch Health Companies Inc, previously known as Valeant Pharmaceuticals, bought Bausch + Lomb from Warburg Pincus.
The parent company had in August 2020 announced its decision to spinoff its eye health business into a separate publicly traded entity, but said that it would retain a majority stake.
Morgan Stanley and Goldman Sachs are the lead underwriters. The company will list under the symbol ‘BLCO,’ according to a filing .
© Thomson Reuters 2021
Financial Post Top Stories Sign up to receive the daily top stories from the Financial Post, a division of Postmedia Network Inc.
By clicking on the sign up button you consent to receive the above newsletter from Postmedia Network Inc. You may unsubscribe any time by clicking on the unsubscribe link at the bottom of our emails. Postmedia Network Inc. | 365 Bloor Street East, Toronto, Ontario, M4W 3L4 | 416-383-2300